This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Join BNMS | Print Page | Contact Us | Sign In
UKRG Guidelines - Guidance notes

UKRG Guidelines - Guidance notes

In order to manage the workload in the Radiopharmacy, it is important to establish the capacity of the unit. UKRG Capacity Planning Guidance is available to download below:

UKRG_Capacity_Planning_Guidance_Sep18.pdf

UKRG_Capacity_Planning_Spreadsheet_Notes.pdf

UKRG_Capacity_Planning_Tool_1.xls

Please read the guidance document "Key Performance Indicators (KPIs) in Radiopharmacy"

PDF Document

Please read the guidance document "The Responsibilities of Chief Pharmacists for the Purchase, Receipt, Storage, Supply and Disposal of Radiopharmaceuticals"

PDF

Please read the guidance document "Addendum to Safe Drawing up document for 223Ra Radium"

PDF

Please read the guidance document "Guidance for Introduction of a 68Ge/68Ga Generator and Labelling Service into Routine Clinical Practice"

PDF

Joint working party of the UK Radiopharmacy Group and NHS Pharmaceutical Quality Assurance Committee

Link pdf

(amended Nov-16)

Guidelines for the Provision of Radiopharmacy Services in the UK

A report has been published by Nuclear Medicine Communications on guidelines for the provision of radiopharmacy support to nuclear medicine. Updated March 2017

link here

Advice for Nuclear Medicine Departments following discontinuation of licensed radiopharmaceuticals and kits from the home market.

The discontinued products paper has been produced as a result of the BNMS summit meeting in February 2009 and has been given the approval of the MHRA by Graham Matthew who was also present at the summit.

UK Radiopharmacy Group

link pdf

Abstract

This document is intended to reflect best practice for the radiolabelling of blood components in the UK, and is offered to the Nuclear Medicine community as a reference source based on opinions and experience from senior practitionrs of radiopharmacy.

Very little evidence-based information exists on the subject, and thus the guidance represents current agreed practice in the field.

link pdf

 

© 2013 BNMS unless otherwise stated.
The BNMS is a registered as a company in England and Wales with number 08082786.  The BNMS is a charity governed by the rules of the Charity Commission for England and Wales - Registered Number 1150234.  Registered Office: The Royal College of Physicians, 11 St. Andrew's Place, Regent's Park, London NW1 4LE.
The British Nuclear Medicine Society is not able to give specific clinical advice to members of the public. If you are concerned about your scan or therapy please seek the opinion of a nuclear medicine clinician where you were seen or the clinician who referred you to the department or your GP.
Enquiries related to issues such as internships and work experience opportunities, should be directed to the relevant professional body e.g., for radiologists, this will be the Royal College of Radiologists.